Resources

First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics

American journal of medical genetics. Part A, Vol. 179, Issue 6, Pages 1091-1097, 2019

PMID: 30908877

The neurofibromatoses, which include neurofibromatosis type I (NF1), neurofibromatosis type II (NF2), and schwannomatosis, are a group of syndromes characterized by tumor growth in the nervous system. The RASopathies are a group of syndromes caused by germline mutations in genes that encode components of the RAS/mitogen-activated protein kinase (MAPK) pathway.

Read More

  https://www.ncbi.nlm.nih.gov/pubmed/30908877

 

Considering Genomic Research?

    Fields marked in * is mandatory to fill
     
     
     

    2024 © MedGenome • All Rights Reserved
    Request a Quote